|
Mar 15
|
2 Beaten-Down Stocks Near Their 52-Week Lows That Aren't Worth Buying
|
|
Mar 11
|
Need To Know: Analysts Just Made A Substantial Cut To Their Novavax, Inc. (NASDAQ:NVAX) Estimates
|
|
Mar 11
|
Novavax Announces Changes to Board of Directors
|
|
Mar 1
|
Novavax, Inc. (NASDAQ:NVAX) Shares Could Be 45% Below Their Intrinsic Value Estimate
|
|
Feb 28
|
1 Biotech Stock to Buy in 2025, and 1 to Avoid
|
|
Feb 28
|
Novavax Inc (NVAX) Q4 2024 Earnings Call Highlights: Strategic Partnerships and Financial ...
|
|
Feb 27
|
Novavax to Participate in Upcoming March Investor Conferences
|
|
Feb 27
|
Marathon, Warner Bros. Discovery, Novavax: Market Minute
|
|
Feb 27
|
Novavax Q4 Loss Narrower Than Expected, Sales Beat Estimates
|
|
Feb 27
|
Novavax rising after reporting narrower Q4 loss, revenue beat
|
|
Feb 27
|
Novavax Reports Smaller Q4 Loss, Shifts Focus From Commercializing COVID-19 Vaccine To Maximize Value
|
|
Feb 27
|
Novavax reports large quarterly revenue declines, rethinks its strategic direction
|
|
Feb 27
|
Novavax shares up on fourth quarter earnings beat
|
|
Feb 27
|
Novavax (NVAX) Reports Q4 Loss, Tops Revenue Estimates
|
|
Feb 27
|
Novavax: Q4 Earnings Snapshot
|
|
Feb 27
|
Novavax sees royalties, reduced expenses on COVID vaccines from Sanofi partnership
|
|
Feb 27
|
Novavax Stock Is Rising. Revenue Beats Estimates.
|
|
Feb 27
|
Novavax Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights
|
|
Feb 24
|
What's in Store for These 5 Biotech Stocks This Earnings Season?
|
|
Feb 24
|
Vaccine Stocks Rise as Chinese Scientists Discover a New Coronavirus
|